Matchpoint launches to advance covalent drug discoverynews2022-10-17T04:00:00+00:00October 17th, 2022|Chemical & Engineering News|
Sponsored content: Safety, respect, and belonging for LGBTQ+ scientistsnews2022-10-17T00:23:22+00:00October 17th, 2022|Chemical & Engineering News|
Science communication that breaks the moldnews2022-10-15T18:03:52+00:00October 15th, 2022|Chemical & Engineering News|
Evonik will make drug active ingredient for Phathomnews2022-10-15T18:02:56+00:00October 15th, 2022|Chemical & Engineering News|
Ochre Bio raises $30 million for RNA-based liver disease therapiesnews2022-10-15T18:02:40+00:00October 15th, 2022|Chemical & Engineering News|
Merck signs drug development deals with Moderna, Royalty Pharmanews2022-10-15T18:02:40+00:00October 15th, 2022|Chemical & Engineering News|
Investor says Hanwha’s stake in REC is a conflict of interestnews2022-10-15T18:02:39+00:00October 15th, 2022|Chemical & Engineering News|
Ginkgo to back Merck with biocatalystsnews2022-10-15T18:02:39+00:00October 15th, 2022|Chemical & Engineering News|
Electra raises cash to electrify steelmakingnews2022-10-15T18:02:39+00:00October 15th, 2022|Chemical & Engineering News|
Biohaven relaunches with new focus after Pfizer acquisitionnews2022-10-15T18:02:39+00:00October 15th, 2022|Chemical & Engineering News|
